Estimation of hepatic proton-density fat fraction by using MR imaging at 3.0 T

Radiology

Volumn 258, Issue 3, 2011, Pages 749-759

  Yokoo, Takeshi ^a   Shiehmorteza, Masoud ^a   Hamilton, Gavin ^a   Wolfson, Tanya ^a   Schroeder, Michael E ^a   Middleton, Michael S ^a   Bydder, Mark ^a   Gamst, Anthony C ^a   Kono, Yuko ^b   Kuo, Alexander ^b   Patton, Heather M ^b   Horgan, Santiago ^a   Lavine, Joel E ^c   Schwimmer, Jeffrey B ^c   Sirlin, Claude B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; CLASSIFICATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; FATTY LIVER; FEMALE; HEPATIC PROTON DENSITY FAT FRACTION; HEPATOBILIARY PARAMETERS; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTON NUCLEAR MAGNETIC RESONANCE; RISK FACTOR; SCHOOL CHILD; SPECTROSCOPY; SYSTEMATIC ERROR;

ADOLESCENT; ADULT; CHILD; FATTY LIVER; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LINEAR MODELS; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSPECTIVE STUDIES; PROTONS; RISK FACTORS;

EID: 79952309399     PISSN: 00338419     EISSN: 15271315     Source Type: Journal    
DOI: 10.1148/radiol.10100659     Document Type: Article

References (62)

1. Brunt EM. Alcoholic and nonalcoholic steatohepatitis. Clin Liver Dis 2002;6(2):399-420, vii.
2. Forgione A, Miele L, Cefalo C, Gasbarrini G, Grieco A. Alcoholic and nonalcoholic forms of fatty liver disease. Minerva Gastroenterol Dietol 2007;53(1):83-100. (Pubitemid 46975317)
3. Leandro G, Mangia A, Hui J, et al. Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data. Gastroenterology 2006;130(6):1636-1642.
4. Björnsson E, Angulo P. Hepatitis C and steatosis. Arch Med Res 2007;38(6):621-627.
5. Negro F, Sanyal AJ. Hepatitis C virus, steatosis and lipid abnormalities: clinical and pathogenic data. Liver Int 2009;29(suppl 2):26-37.
6. Ramachandran R, Kakar S. Histological patterns in drug-induced liver disease. J Clin Pathol 2009;62(6):481-492.
7. Zorzi D, Laurent A, Pawlik TM, Lauwers GY, Vauthey JN, Abdalla EK. Chemotherapy-associated hepatotoxicity and surgery for colorectal liver metastases. Br J Surg 2007;94(3):274-286. (Pubitemid 46423843)
8. Diehl AM. Alcoholic liver disease: natural history. Liver Transpl Surg 1997;3(3):206-211. (Pubitemid 27218049)
9. Matteoni CA, Younossi ZM, Gramlich T, Boparai N, Liu YC, McCullough AJ. Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 1999;116(6):1413-1419. (Pubitemid 29258890)
10. Angulo P, Keach JC, Batts KP, Lindor KD. Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis. Hepatology 1999;30(6):1356-1362.
11. Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr Gastroenterol Rep 2005;7(1):32-36.
12. Amarapurka DN, Amarapurkar AD, Patel ND, et al. Nonalcoholic steatohepatitis (NASH) with diabetes: predictors of liver fibrosis. Ann Hepatol 2006;5(1):30-33.
13. Ekstedt M, Franzén LE, Mathiesen UL, et al. Long-term follow-up of patients with NAFLD and elevated liver enzymes. Hepatology 2006;44(4):865-873. (Pubitemid 46489550)
14. Adams LA, Waters OR, Knuiman MW, Elliott RR, Olynyk JK. NAFLD as a risk factor for the development of diabetes and the metabolic syndrome: an eleven-year follow-up study. Am J Gastroenterol 2009;104(4):861-867.
15. Schindhelm RK, Diamant M, Heine RJ. Nonalcoholic fatty liver disease and cardiovascular disease risk. Curr Diab Rep 2007;7(3):181-187. (Pubitemid 46951915)
16. Targher G, Bertolini L, Rodella S, et al. Nonalcoholic fatty liver disease is independently associated with an increased incidence of cardiovascular events in type 2 diabetic patients. Diabetes Care 2007;30(8):2119-2121. (Pubitemid 47219432)
17. Schwimmer JB, Pardee PE, Lavine JE, Blumkin AK, Cook S. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008;118(3):277-283.
18. Dunn W, Xu R, Wingard DL, et al. Suspected nonalcoholic fatty liver disease and mortality risk in a population-based cohort study. Am J Gastroenterol 2008;103(9):2263-2271.
19. Rubinstein E, Lavine JE, Schwimmer JB. Hepatic, cardiovascular, and endocrine outcomes of the histological subphenotypes of nonalcoholic fatty liver disease. Semin Liver Dis 2008;28(4):380-385.
20. Powell EE, Jonsson JR, Clouston AD. Steatosis: co-factor in other liver diseases. Hepatology 2005;42(1):5-13. (Pubitemid 40911303)
21. Ueno T, Sugawara H, Sujaku K, et al. Therapeutic effects of restricted diet and exercise in obese patients with fatty liver. J Hepatol 1997;27(1):103-107. (Pubitemid 27357062)
22. Hickman IJ, Jonsson JR, Prins JB, et al. Modest weight loss and physical activity in overweight patients with chronic liver disease results in sustained improvements in alanine aminotransferase, fasting insulin, and quality of life. Gut 2004;53(3):413-419. (Pubitemid 38241340)
23. Huang MA, Greenson JK, Chao C, et al. One-year intense nutritional counseling results in histological improvement in patients with non-alcoholic steatohepatitis: a pilot study. Am J Gastroenterol 2005;100(5):1072-1081. (Pubitemid 40769044)
24. Musso G, Gambino R, Cassader M. Nonalcoholic fatty liver disease from pathogenesis to management: an update. Obes Rev 2010;11(6):430-435.
25. Tendler D, Lin S, Yancy WS Jr, et al. The effect of a low-carbohydrate, ketogenic diet on nonalcoholic fatty liver disease: a pilot study. Dig Dis Sci 2007;52(2):589-593. (Pubitemid 46202845)
26. Thampanitchawong P, Piratvisuth T. Liver biopsy: complications and risk factors. World J Gastroenterol 1999;5(4):301-304.
27. Joy D, Thava VR, Scott BB. Diagnosis of fatty liver disease: is biopsy necessary? Eur J Gastroenterol Hepatol 2003;15(5):539-543.
28. Ratziu V, Charlotte F, Heurtier A, et al. Sampling variability of liver biopsy in nonalcoholic fatty liver disease. Gastroenterology 2005;128(7):1898-1906. (Pubitemid 40824701)
29. Janiec DJ, Jacobson ER, Freeth A, Spaulding L, Blaszyk H. Histologic variation of grade and stage of non-alcoholic fatty liver disease in liver biopsies. Obes Surg 2005;15(4):497-501. (Pubitemid 40605072)
30. Ratziu V, Bugianesi E, Dixon J, et al. Histological progression of non-alcoholic fatty liver disease: a critical reassessment based on liver sampling variability. Aliment Pharmacol Ther 2007;26(6):821-830. (Pubitemid 47346702)
31. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94(9):2467-2474. (Pubitemid 29420675)
32. Sanyal AJ;American Gastroenterological Association. AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002;123(5):1705-1725.
33. Kleiner DE, Brunt EM, Van Natta M, et al. Design and validation of a histological scoring system for nonalcoholic fatty liver disease. Hepatology 2005;41(6):1313-1321. (Pubitemid 40770284)
34. Longo R, Pollesello P, Ricci C, et al. Proton MR spectroscopy in quantitative in vivo determination of fat content in human liver steatosis. J Magn Reson Imaging 1995;5(3):281-285.
35. Thomsen C, Becker U, Winkler K, Christoffersen P, Jensen M, Henriksen O. Quantification of liver fat using magnetic resonance spectroscopy. Magn Reson Imaging 1994;12(3):487-495. (Pubitemid 24113193)
36. Szczepaniak LS, Babcock EE, Schick F, et al. Measurement of intracellular triglyceride stores by H spectroscopy: validation in vivo. Am J Physiol 1999;276(5 pt 1):E977-E989. (Pubitemid 29249618)
37. Reeder S, Hines C, Yu H, McKenzie C, Brittain J. On the definition of fat-fraction for in vivo fat quantification with magnetic resonance imaging [abstr]. In: Proceedings of the Seventeenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009; 211.
38. Szczepaniak LS, Nurenberg P, Leonard D, et al. Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population. Am J Physiol Endocrinol Metab 2005;288(2):E462-E468. (Pubitemid 40110657)
39. Hamilton G, Middleton MS, Bydder M, et al. Influence of MR spectroscopy sequence on the measurement of IHCL levels [abstr]. In: Radiological Society of North America Scientific Assembly and Annual Meeting Program. Oak Brook, Ill: Radiological Society of North America, 2007; 548.
40. Middleton M, Hamilton G, Bydder M, Sirlin C. How much fat is under the water peak in liver fat MR spectroscopy? [abstr]. In: Proceedings of the Seventeenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009; 4331.
41. Hussain HK, Chenevert TL, Londy FJ, et al. Hepatic fat fraction: MR imaging for quantitative measurement and display - early experience. Radiology 2005;237(3):1048-1055. (Pubitemid 41636400)
42. Liu CY, McKenzie CA, Yu H, Brittain JH, Reeder SB. Fat quantification with IDEAL gradient echo imaging: correction of bias from T(1) and noise. Magn Reson Med 2007;58(2):354-364. (Pubitemid 47267653)
43. Yokoo T, Collins JM, Hanna RF, Bydder M, Middleton MS, Sirlin CB. Effects of intravenous gadolinium administration and flip angle on the assessment of liver fat signal fraction with opposed-phase and in-phase imaging. J Magn Reson Imaging 2008;28(1):246-251. (Pubitemid 351956490)
44. Guiu B, Petit JM, Loffroy R, et al. Quantification of liver fat content: comparison of triple-echo chemical shift gradient-echo imaging and in vivo proton MR spectroscopy. Radiology 2009;250(1):95-102.
45. Yu H, McKenzie CA, Shimakawa A, et al. Multiecho reconstruction for simultaneous water-fat decomposition and T2* estimation. J Magn Reson Imaging 2007;26(4):1153-1161. (Pubitemid 47548182)
46. Bydder M, Yokoo T, Hamilton G, et al. Relaxation effects in the quantification of fat using gradient echo imaging. Magn Reson Imaging 2008;26(3):347-359.
47. O'Regan DP, Callaghan MF, Wylezinska-Arridge M, et al. Liver fat content and T2*: simultaneous measurement by using breath-hold multiecho MR imaging at 3.0 T - feasibility. Radiology 2008;247(2):550-557.
48. Yu H, Shimakawa A, McKenzie CA, Brodsky E, Brittain JH, Reeder SB. Multiecho water-fat separation and simultaneous R2* estimation with multifrequency fat spectrum modeling. Magn Reson Med 2008;60(5):1122-1134.
49. Reeder SB, Robson PM, Yu H, et al. Quantification of hepatic steatosis with MRI: the effects of accurate fat spectral modeling. J Magn Reson Imaging 2009;29(6):1332-1339.
50. Yokoo T, Bydder M, Hamilton G, et al. Nonalcoholic fatty liver disease: diagnostic and fat-grading accuracy of low-flip-angle multiecho gradient-recalled-echo MR imaging at 1.5 T. Radiology 2009;251(1):67-76.
51. Hamilton G, Middleton M, Shiehmorteza M, Sirlin C. The effect of J-coupling on absolute quantification of liver fat using MRS: a phantom study [abstr]. In: Proceedings of the Seventeenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009;2149.
52. Hamilton G, Middleton MS, Bydder M, et al. Effect of PRESS and STEAM sequences on magnetic resonance spectroscopic liver fat quantification. J Magn Reson Imaging 2009;30(1):145-152.
53. Bydder M, Hamilton G, Yokoo T, Sirlin CB. Optimal phased-array combination for spectroscopy. Magn Reson Imaging 2008;26(6):847-850.
54. Vanhamme L, van den Boogaart A, Van Huffel S. Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 1997;129(1):35-43. (Pubitemid 127454051)
55. Naressi A, Couturier C, Castang I, de Beer R, Graveron-Demilly D. Java-based graphical user interface for MRUI, a software package for quantitation of in vivo/medical magnetic resonance spectroscopy signals. Comput Biol Med 2001;31(4):269-286. (Pubitemid 32378728)
56. Dixon WT. Simple proton spectroscopic imaging. Radiology 1984;153(1):189-194. (Pubitemid 14043406)
57. Fishbein MH, Stevens WR. Rapid MRI using a modified Dixon technique: a noninvasive and effective method for detection and monitoring of fatty metamorphosis of the liver. Pediatr Radiol 2001;31(11):806-809. (Pubitemid 33040146)
58. Efron B. Better bootstrap confidence intervals. J Am Stat Assoc 1987;82(397):171-185.
59. Hochberg A. A sharper Bonferroni procedure for multiple tests of significance. Biometrika 1988;75(4):800-802.
60. Hines CD, Yu H, Shimakawa A, et al. Quantification of hepatic steatosis with 3-T MR imaging: validation in ob/ob mice. Radiology 2010;254(1):119-128.
61. Qayyum A, Goh JS, Kakar S, Yeh BM, Merriman RB, Coakley FV. Accuracy of liver fat quantification at MR imaging: comparison of out-of-phase gradient-echo and fat-saturated fast spin-echo techniques - initial experience. Radiology 2005;237(2):507-511. (Pubitemid 41507887)
62. Yokoo T, Bydder M, Hamilton G, et al. Effect of fat spectral model parameters on hepatic fat quantification by multi-echo gradient-echo magnetic resonance imaging [abstr]. In: Proceedings of the Seventeenth Meeting of the International Society for Magnetic Resonance in Medicine. Berkeley, Calif: International Society for Magnetic Resonance in Medicine, 2009;2134.